ABSTRACT
INTRODUCTION

5
Bile acids (BAs) have long been regarded as digestive detergents for cholesterol 4 6 elimination, but are emerging as important signaling molecules that regulate the 4 7 metabolism of triglyceride, cholesterol, and glucose 1,2 , and thus, are critically involved in 4 8 the development of type 2 diabetes mellitus 3,4 . Glucagon-like peptide-1 (GLP-1) is an 0 glucose homeostasis is mainly mediated through promotion of intestinal secretion of 3 0 1 GLP-1.
3 0 2 An interesting finding in our study was that although all of the BAs including HCA 3 0 3 species have the effect on stimulating GLP-1 secretion, the dose effects were different. 3 0 7 Such a unique feature of HCA species suggested that HCA and derivatives could be 3 0 8 applied with sufficiently high concentrations (pharmacological levels) in maintaining 3 0 9 glucose homeostasis, thus having great potential for therapeutic applications.
In clinical studies, T2DM is inherently associated with obesity and aging 32 , so we 3 1 1 tried to eliminate the confounding effects of BMI and age when evaluating the role of 3 1 2 HCA species in T2DM. By matching age and/or BMI between the groups in comparison, 3 1 3 we demonstrated that HCA species had direct correlations with glycemic markers and 3 1 4 future metabolic outcome. These results provide evidence that HCA species play critical 3 1 5 roles in regulating glucose homeostasis and are protective against the development of 3 1 6 T2DM in humans.
1 7
We also showed that, compared with healthy controls, pre-diabetic and diabetic 3 1 8 patients had ~27 % lower serum levels of HCA species, but strikingly ~57 % lower HCA 3 1 9 species in feces, although these patients had similar levels of total BAs in feces as 3 2 0 controls. Notably the pre-diabetic and diabetic patients had higher BMIs than the healthy 3 2 1 controls, which suggest that they may also have altered gut microbiota 33 . Intestinal 3 2 2 microbiota are known to play a critical role in BA metabolism [34] [35] [36] . Obesity and/or 3 2 3 diabetes-associated changes in gut microbiota may inhibit the generation or facilitate the 3 2 4 metabolism of HCA species, which, in turn, could lead to their depletion in feces. We 3 2 5 further showed that fecal HCA species had stronger inverse correlations with glycemic 3 2 6 markers than serum HCA species after adjusting for age, sex, and BMI, suggesting that 3 2 7 the intestinal track is a critical site for HCA-mediated glycemic regulation.
3 2 8 RYGB surgery is considered a rapid resolution of T2DM. Both HCA and GHCA were 3 2 9 found significantly increased after RYGB 11 . We found that in addition to HCA and GHCA, 3 3 0 HDCA and GHDCA were also increased drastically after RYGB; and among all BAs, the 3 3 1 increases in HCA species were the most pronounced and consistent (Table S12 ). Our The composition of the BA profile especially HCA species varies markedly among 3 3 7 mammalian species. We show in this study that obesity and diabetes were closely 3 3 8 associated with significant lower levels of HCA species in serum. Furthermore, the 3 3 9 concentrations of HCA species in both serum and feces were closely correlated with 3 4 0 glycemic markers and were strong predictors of future metabolic outcome in apparently 11.1 mmol/L were used in the study (n = 32). Thirty-two HFD+STZ mice were divided 4 7 2 into four groups and were orally administrated with the following agents for 28 days: 1) 4 7 3 control group: mice (n = 8) were administered with control vehicle, 6 % NaHCO 3 ; 2) 4 7 4 metformin group: mice (n = 8) were administered with metformin at a daily dose of 200 4 7 5 mg/kg/day; 3) HCA group: mice (n = 8) were administered with HCA at a daily dose of 4 7 6 100 mg/kg/day; 4) HDCA group: mice (n = 8) were administered with HDCA at a daily 4 7 7 dose of 100 mg/kg/day. following agents for 28 days: 1) control group: mice (n = 5) were administered with 4 9 0 control vehicle, 6 % NaHCO 3 (i.g.); 2) HCA group: mice (n = 5) were administered with 4 9 1 HCA (100 mg/kg/day, i.g.); 3) 5β-CA group: mice (n = 5) were administered with control 4 9 2 vehicle, 6 % NaHCO 3 (i.g.), and 5β-CA (C7628, Sigma-Aldrich) in 0.5 % Sodium 4 9 3 Carboxymethyl Cellulose (CMC-Na; 419338, Sigma-Aldrich) (100 mg/kg/day, i.g.); 4) 4 9 4 HCA+5β-CA group: mice (n = 5) were administered with HCA (100 mg/kg/day, i.g.), and 4 9 5 5β-CA in 0.5 % CMC-Na (100 mg/kg/day, i.g.); 5) FEX group: mice (n = 5) were 4 9 6 administered with control vehicle, 6 % NaHCO 3 (i.g.), and FEX (Hanxiang Corp.) in 0.5 % 4 9 7 CMC-Na (100 mg/kg/day, i.g.); 6) HCA+FEX group: mice (n = 5) were administered with 4 9 8 HCA (100 mg/kg/day, i.g.), and FEX in 0.5 % CMC-Na (100 mg/kg/day, i.g.). 7) Exendin 4 9 9 group: mice (n = 5) were administered with control vehicle, 6 % NaHCO 3 (i.g.), and 
